The company also announced a seed round co-led by Cubit Capital and Construct Capital bringing total funding to $14 million

WASHINGTON, April 29, 2026 — Kibu, the human network and app-based platform that enables individuals and organizations to know exactly who they’re interacting with when it matters most, today announced a $10.5 million seed round to scale its platform. Leveraged by the world’s most discerning users, the platform is in use today across financial services, security consulting, family offices, and government agencies. The round was co-led by Cubit Capital and Construct Capital with major participation from Slow Ventures and Helena, and joined by angels like Nicole Perlroth, Judy Estrin, and David Carrico. This brings Kibu’s total funding to $14 million.

“The first era of digital and social networks was about reach as the platforms made it easy to find people, follow them, and share content at scale, but identity has been assumed, not verified,” said Ari Andersen, co-founder and CEO of Kibu. “In today’s world of deepfakes, bots, and AI-fraud, the critical question has shifted from ‘Who can I reach?’ to ‘Who can I trust?’ In a world where AI can fool any single verification moment, the only durable proof of identity is the network of real relationships around you.”

The Problem: Trust Can No Longer Be Assumed

It has never been harder to know who and what to trust. For decades, organizations have relied on identity-by-assumption: if the email address looks right, if the phone number matches, it’s trusted. That assumption is breaking down.

Credentials themselves have become the primary attack vector. Email accounts get compromised, phone numbers get spoofed through SIM swaps, and AI can now fake anyone in seconds.

Traditional security tools encrypt the channel, but they can’t verify the person. End-to-end encryption doesn’t prevent talking to an imposter. When the most consequential decisions happen across informal channels (Signal threads, WhatsApp groups, personal phones), there’s no way to establish trust before communication occurs. Kibu solves this by turning real-world trust into secure digital connections, establishing verification before communication occurs.

Kibu’s Approach: Building Trust Before It Matters

Whereas most security tools look for threats in real-time, Kibu fills an important gap in the market by launching a platform that establishes trust before it matters. By verifying human identity upfront, Kibu builds trust into the system rather than bolting it on afterward.

The Kibu app verifies its users through a simple, one-time process that binds identity to biometric-protected devices using liveness testing and cryptographic proof. This lets users build a network of confirmed contacts called Connections. Non-discoverable by design, Connections ensure that if someone is not invited, they cannot find you, contact you, or observe your network. Within this verified network, users can securely communicate, share sensitive information, and make group decisions knowing exactly who they’re talking to.

“We took military-grade cryptography and wrapped it in a consumer-focused product,” said Eftychis Gregos-Mourginakis, co-founder and COO of Kibu. “We anchor identity in real human relationships, verified cryptographically, and put control in the hands of users.”

Why Investors Are Backing Kibu

“The industry’s answer to AI threats has been more AI — an arms race with no finish line,” said Philip Carson, Partner at Cubit Capital. “Kibu reframes the problem around people and the relationships they actually trust. As work moves into informal channels, that’s the network that matters.”

“The identity verification market is growing rapidly and will exceed $150 billion by the 2030s as AI-driven impersonation accelerates,” said Rachel Holt, Cofounder and Managing Partner at Construct Capital. “As deception scales, demand for human-verified trust grows with it, and Kibu is uniquely positioned to serve the people and organizations at the center of these networks.”

With the new funding, Kibu will scale adoption and focus on building out its infrastructure to bring its trust fabric to other tools and workflows.

About Kibu

Kibu is a human network and app-based platform that enables individuals and organizations to know exactly who they’re interacting with when it matters most. Leveraged by the world’s most discerning users, it turns real-world trust into secure digital connections for high-stakes work in the AI era. Kibu cryptographically binds real human identity to verified interactions, enabling trusted communication, authorization, and decisions where trust must be established before action occurs.

Founded by experts in cybersecurity policy and privacy stewardship, Kibu is trusted by financial institutions, defense contractors, and security consultants coordinating sensitive work across organizational boundaries. Kibu is backed by Cubit Capital, Construct Capital, Slow Ventures, and Silver Buckshot Ventures.

For more information, download the Kibu app, visit the website, and follow Kibu on LinkedIn.

SOURCE Kibu, Inc.

The category leader in AI for 250+ global investment banks and investment firms raises new capital to deepen institutional partnerships, scale its agentic platform, and accelerate global expansion

NEW YORK, April 29, 2026 — Rogo, the AI platform purpose-built for finance, today announced it has raised $160 million in Series D funding led by Kleiner Perkins, with participation from Sequoia, Thrive Capital, Khosla Ventures, J.P. Morgan Growth Equity Partners, BoxGroup, Mantis VC, Jack Altman, Evantic and Positive Sum. The Series D brings Rogo’s total funding to more than $300 million and positions Rogo to accelerate the company’s global expansion, deepen its partnerships with the world’s leading financial institutions, and scale its AI agent, Felix.

This investment comes at a time when AI in financial services is at an inflection point. The world’s leading financial firms are now moving to rebuild their operating models around AI: restructuring workflows, rethinking staffing pyramids, and deploying autonomous agents that work asynchronously across every transaction, every portfolio, and every relationship.

Rogo is the long-term AI transformation partner for the institutions navigating this shift, delivering state of the art agents, forward-deployed bankers and engineers, and deep domain expertise at the nexus of finance; security, legal, and regulatory issues; and applied AI.

More than 35,000 financial professionals at over 250 institutions, including Rothschild & Co, Jefferies, Lazard, Moelis, Nomura, and others, leverage Rogo in their daily workflows across origination, execution, advisory, and portfolio intelligence.

“The world’s most sophisticated financial institutions are fundamentally reshaping how they operate using AI, and they’re choosing to do it with Rogo,” said Gabriel Stengel, CEO and Co-Founder of Rogo. “The institutions at the forefront are rapidly moving beyond automating tasks to becoming AI-native firms, with agentic systems that work across the firm and get smarter with every deal.”

Rogo’s platform operates in concert with how financial institutions think, work, and make decisions. The company recently introduced Felix, its agentic AI that executes complex, multi-step financial processes autonomously, from deal screening and CIM generation to buyer outreach and data room diligence.

“Rogo has built an AI platform that the most demanding institutions in finance trust with their most critical workflows,” said Mamoon Hamid, Partner at Kleiner Perkins. “Their combination of technical depth, proprietary data integrations, and genuine domain expertise is why Rogo is pulling away from the field. When a platform becomes the operating system for an entire industry, the opportunity is generational.”

About Rogo
Rogo is the leading generative AI platform built for financial services. Trusted by more than 35,000 professionals at the world’s top investment banks, private equity firms, and asset managers, Rogo combines purpose-built financial reasoning models with deep integrations across internal and external data sources to automate research, accelerate workflows, and deliver analyst-grade insights in seconds. For more information, visit rogo.ai.

Press Contact:
[email protected]

SOURCE Rogo

The funding accelerates expansion of Aidoc’s clinical foundation model and enterprise AI platform to combat diagnostic harm and improve efficiency across health systems.

NEW YORK, April 29, 2026 — Aidoc, a global leader in clinical AI, has raised $150 million in Series E funding led by Growth Equity at Goldman Sachs Alternatives. The round had participation from General Catalyst, SoftBank Investment Advisors and NVentures (NVIDIA’s venture capital arm). The round brings total funding to over $500 million, less than a year after a growth round led by General Catalyst and Square Peg. This underscores the pace of Aidoc’s momentum and the accelerating demand for enterprise-scale clinical AI.

Diagnostic errors and delays contribute to at least 400,000 deaths each year in the United States, driven by rising imaging volumes, workforce shortages and growing clinical complexity. While AI has long promised to reduce that burden, most tools have tackled one use case at a time, limiting their impact at scale.

As hospitals seek broader, system-wide solutions, the market is shifting toward clinical AI deployed across entire health systems. Foundation models have made that shift technically possible by enabling expanded coverage across conditions and imaging modalities from a single architecture. Translating that capability into regulated, real-world care, however, has proven far more complex. Aidoc developed its own clinical foundation model, CARE™, and deployed it through its enterprise platform, aiOS™. Earlier this year, CARE received a landmark first FDA clearance for a comprehensive double-digit foundation model-based triage system in clinical imaging. Today, the company analyzes more than 60 million patient cases annually and is deployed across nearly 2,000 hospitals, signaling a new phase in the adoption of clinical AI.

“By 2030, every complex diagnostic decision should be supported by AI that enables earlier detection and reduces preventable error,” said Elad Walach, co-founder and CEO of Aidoc. “We feel a deep responsibility to deploy CARE safely and at scale across health systems. This funding accelerates comprehensive disease coverage and advances end-to-end AI across CT and X-ray, spanning the full workflow including pixel to draft report within two years.”

As clinical AI moves to enterprise deployment, a determining factor is governance and regulatory discipline. In large, complex health systems, scale requires not only advanced technology but the oversight and accountability needed to operate safely in real-world care.

“Aidoc pairs advanced technology with regulatory rigor in a way that few companies have achieved,” said Christian Resch, Partner at Growth Equity at Goldman Sachs Alternatives. “Health systems consistently describe tangible results, including improved radiology efficiency, shorter lengths of stay, and measurable financial returns. We believe this combination of innovation, safety, technical rigor, and operational discipline positions Aidoc as a long-term leader in clinical AI.”

The new capital will support further development of Aidoc’s CARE foundation model, expansion into additional clinical indications, and new capabilities such as automated imaging draft report creation to power end-to-end clinical AI workflows. It will also drive broader global deployment of its aiOS enterprise AI platform as hospitals consolidate standalone tools under centralized operating frameworks designed to manage and govern AI at scale.

About Aidoc
Aidoc is a global leader in clinical AI focused on helping physicians make earlier, safer diagnoses by turning raw patient signals into actionable insight. The company is powered by its breakthrough CARE™ foundation model and an enterprise AI platform, Aidoc aiOS™, embedding AI directly into clinical workflows, enabling health systems to deploy, manage and scale multiple FDA-cleared solutions through a centralized operating layer. Aidoc’s technology has analyzed more than 110 million patient cases and is deployed in nearly 2,000 hospitals worldwide, supporting clinical decision-making for approximately 60 million patients each year.

About Growth Equity at Goldman Sachs Alternatives
Goldman Sachs is one of the leading investors in alternatives globally, with over $625 billion in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives, including private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Clients access these solutions through direct strategies, customized partnerships, and open-architecture programs.

The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets.

The alternative investments platform is part of Goldman Sachs Asset Management, which delivers investment and advisory services across public and private markets for the world’s leading institutions, financial advisors, and individuals. Goldman Sachs has approximately $3.6 trillion in assets under supervision globally as of December 31, 2025.

Since 2003, Growth Equity at Goldman Sachs Alternatives has invested over $13 billion in companies led by visionary founders and CEOs. The team focuses on investments in growth-stage and technology-driven companies spanning multiple industries, including enterprise technology, financial technology, consumer and healthcare.

Media Contact
Sarah Small
[email protected]         
1 (929) 255 1449

SOURCE Aidoc

Agentic platform enabling data lakehouse teams to reduce platform costs, improve reliability, and accelerate data and AI delivery

CHICAGO, April 29, 2026 — definity today unveiled its agentic data engineering platform, purpose-built to operate and optimize enterprise lakehouse and Spark data pipelines. The company also announced an oversubscribed $12 million Series A financing led by GreatPoint Ventures, with participation from Dynatrace and existing investors StageOne Ventures and Hyde Park Venture Partners. The round brings definity’s total funding to $16.5 million.

The Operational Gap in Modern Data Platforms

Enterprise data platforms now underpin AI, analytics, and core business operations. Data engineering teams are expected to deliver faster while maintaining production reliability and controlling costs across increasingly complex environments.

However, most teams still operate with fragmented tooling that monitors isolated signals – data quality, execution health, infrastructure performance, or spend – after the fact and without a unified operational context. As a result, data engineering remains reactive and manual, and more importantly, AI agents lack the runtime understanding required to take effective action and operate safely in production environments.

The outcome is disastrous – significant infrastructure waste, recurring pipeline incidents, and slow data delivery that constrains business outcomes.

definity was built to solve this operational gap.

From Monitoring to Agentic Operation

definity introduces a new operating model for enterprise data platforms: agentic data engineering.

The platform provides actionable runtime intelligence powering AI agents that enable teams to continuously optimize platform cost, prevent incidents before they impact the business, and dramatically increase developer velocity.

At the core of definity is an in-motion architecture that operates directly within production pipelines, without requiring code changes. By observing pipelines during execution, the platform captures full-stack signals across infrastructure behavior, pipeline execution, and data characteristics.

This unified runtime context, combined with the ability to safely control pipeline execution in real time, enables the shift from monitoring to true agentic operation.

Without runtime intelligence and control, AI agents remain advisory and post hoc. With it, they can autonomously analyze, optimize, and take action in production.

“As AI becomes embedded across the enterprise, data platforms can no longer be operated through fragmented, reactive tooling,” said Roy Daniel, CEO and co-founder of definity. “Agentic data engineering introduces a new operating model – agents that continuously understand, optimize, and protect data pipelines in production. definity was purpose-built to deliver on that promise for the enterprise.”

Proven Enterprise Outcomes at Scale

Global enterprises use definity to reduce platform costs by more than 30 percent through job-level optimization, prevent pipeline and data incidents in motion before they impact the business, and resolve complex Spark issues 10 times faster.

The solution supports large lakehouse deployments across both cloud and on-premises Spark environments, including Databricks, AWS EMR, GCP Dataproc, and Spark on K8S. By embedding intelligence directly into pipeline execution, definity simplifies day-to-day platform operations while enabling continuous optimization at enterprise scale. Adoption has accelerated as enterprises seek operational leverage beyond traditional observability tooling in these platforms.

“definity brings much-needed intelligence to the data layer by applying runtime context across data pipelines,” said Steve Tack, Chief Product Officer at Dynatrace. “Their approach directly aligns with our vision of full-stack observability – from applications and infrastructure to data and AI.”

Funding to Scale Agentic Data Engineering

This round comes on the heels of significant momentum for definity, tripling its revenue over the past six months and adding several Fortune 500 and large enterprise customers.

The $12 million Series A will support continued development of definity’s agentic capabilities, expansion of ecosystem integrations, and growth of go-to-market operations.

“definity is solving a problem that becomes unavoidable at enterprise scale,” said Gautam Krishnamurthi, General Partner at GreatPoint Ventures. “Their runtime-first architecture and early traction with high-caliber customers position them to lead the shift toward agentic data engineering – the evolution of the modern data platform.”

As enterprise AI adoption accelerates, data platforms are under unprecedented operational strain. The ability to operate pipelines with full context and autonomous action is becoming essential. definity is the foundational infrastructure for this new era, enabling data engineering teams to move from fragmented monitoring and reactive alerts to proactive, autonomous operation of production data pipelines.

About definity

definity is the agentic data engineering platform for the lakehouse and Spark ecosystem, providing actionable runtime intelligence via AI agents that enable enterprise data engineering teams to optimize platform costs, proactively prevent job and data incidents, and improve developer velocity.

For more information, visit www.definity.ai.

SOURCE definity

NEW YORK, April 29, 2026 — Chord, an AI platform powering modern commerce operations, today announced it has raised $7 million, led by Equal Ventures, with participation from existing investor M13 and new investors Chingona Ventures and CEAS Investments.

Commerce is becoming harder to run. Systems are fragmented, and teams are left stitching together disconnected tools while trying to adopt AI. Without a unified foundation, most brands can’t turn AI into real operational leverage. Chord is built to solve this, unifying the data and operational context needed to power AI across dozens of mid-market and enterprise commerce teams, collectively representing over $1billion in annual revenue. Customers include Mr. Beast, Ritual, Ruggable, Rodan + Fields, and Blue Bottle Coffee, among others. By moving teams away from fragmented tools and dashboards to real-time, AI-powered execution, Chord enables faster decision-making and automates operations at scale.

“Commerce teams do not need more dashboards. They need systems that actually run the business,” said Bryan Mahoney, CEO of Chord. “We’ve rebuilt Chord so AI can operate inside a company with full context, not as an overlay, but as the engine behind decisions and execution. This funding allows us to accelerate that vision and scale the platform for the next generation of commerce teams.”

Chord’s platform enables brands to ask questions, generate insights, and immediately take action, compressing workflows that once required multiple teams and weeks of coordination into minutes. The system is built around a “context graph,” a living operational memory that captures a business’s metrics, rules, historical decisions, constraints, and trade-offs, compounding in accuracy and trust over time. This reflects how a business actually operates, allowing AI to make decisions based on real-world conditions rather than static data models. Teams are expanding Chord usage organically across their organizations, with Copilot usage tripling as teams shift away from traditional business intelligence tools and teams increasingly opening Chord before their legacy analytics tools.

“When you’re putting out products and content at our scale, speed is everything. Chord helps our team use our data to move faster,” says Joshua Maynard, GM, Global eCommerce at Mr. Beast.

“Merchants today run their businesses through a disjointed stack of solutions that can make relatively simple activities extremely manual and time-consuming,” said Ali Afridi, investor at Equal Ventures. “Chord enables operators to centralize and connect their systems in a single control layer, helping them scale more efficiently and infuse AI across their operations without a costly rip-and-replace of their core systems.”

With the new funding, Chord will continue to accelerate the development of its agent infrastructure and scale across mid-market and enterprise commerce and retail brands that generate $20M-$1B in revenue.

About Chord
Chord is the AI platform for modern commerce companies. Built by the team behind Glossier, Chord unifies data, decisions, and actions into a single system that enables AI to run core business operations. The platform powers agentic commerce, helping brands operate more efficiently, scale faster, and make better decisions in real time.

Press contact:
Kathy Osborne
[email protected]
607-434-2065 

SOURCE Chord

BROOMALL, Pa., April 29, 2026 — QualiFi LLC, a provider of strategic business financing solutions, today announced the successful structuring and placement of a $5 million SBA 7(a) loan for a West Coast-based medical staffing company.

The financing will support the company’s continued expansion, enhance working capital flexibility, and position the business for sustained long-term growth in the rapidly evolving healthcare staffing sector.

Approximately 30% of the proceeds were used to refinance higher-cost, short-term debt—significantly improving the company’s capital structure—while the remaining 70% will be deployed toward strategic growth initiatives, including scaling operations and meeting rising demand across its markets.

The borrower, a growing provider of healthcare personnel to hospitals and medical facilities throughout the West Coast, required a flexible and scalable capital solution to better manage payroll cycles, reduce financing costs, and expand operational capacity. Following a comprehensive underwriting and strategic review process, QualiFi LLC structured and secured an SBA-backed facility aligned with both the company’s immediate operational needs and long-term growth objectives.

“This was a case where the business fundamentals were strong, but the capital structure needed to evolve alongside the company’s growth,” said Eddie DeAngelis, Founder and CEO of QualiFi LLC. “By refinancing higher-cost debt and introducing long-term SBA financing, we created greater stability while providing meaningful runway for continued expansion.”

The transaction underscores QualiFi LLC’s differentiated approach—combining in-house underwriting expertise, disciplined deal structuring, and deep lender relationships to deliver tailored financing solutions designed for long-term success.

“Access to the right capital at the right time is critical in healthcare staffing, especially given the pace of demand today,” said a representative of the borrower. “QualiFi LLC took the time to understand our business and delivered a solution that supports where we’re going—not just where we are.”

Continued Growth and Expansion
This transaction comes amid a period of strong momentum for QualiFi LLC, as the firm continues to expand its national footprint and client base.
Year-to-date in 2026, QualiFi LLC has secured more than $80 million in financing across a diverse range of industries and has grown its team to over 30 professionals.
Since its founding, the firm has facilitated more than $400 million in total funding, supporting businesses nationwide with customized, growth-oriented capital solutions.

About QualiFi LLC
QualiFi LLC is a boutique business financing firm specializing in creative structuring and securing capital solutions for small to mid-market companies across the United States. Through a combination of in-house underwriting, strategic lender relationships, and a client-first advisory approach, QualiFi provides access to a comprehensive suite of financing options, including SBA loans, lines of credit, term loans, equipment financing, and asset-based lending solutions.

Media Contact
QualiFi LLC
1974 Sproul Road, Suite 200
Broomall, PA 19008
833.933.3665
[email protected]
GoQualiFi.com

SOURCE QualiFi, LLC

Backed by Decheng Capital, Loyal Valley Capital, OrbiMed, and Other Renowned Investors

SHANGHAI, April 29, 2026 — Vivacta Biotechnology (Shanghai) Co., Ltd. (“Vivacta” or “Vivacta Bio”), an innovative biotechnology company focused on revolutionizing in vivo CAR-T therapies, announces the company recently completed Series A and Series A+ financing of over US$ 50 million. The two series of financing were led by Loyal Valley Capital and Decheng Capital respectively, and participated by renowned investors including OrbiMed, Hankang Capital, Eisai Innovation Inc., C&D Emerging Industry Equity Investment, as well as by existing shareholders such as Qiming Venture Partners, Beijing Shunxi, and Apricot Capital. Investors in Vivacta’s Series A and Series A+ financing comprised global industrial capital and specialist biotechnology investors, whose recognition highlights the potential of Vivacta’s innovative technologies and fuels accelerated clinical development and global operation of the company.

“We are deeply honored by the recognition and support from a group of leading investors“, commented Dr. Liu Yarong, Founder and CEO of Vivacta, “Vivacta is committed to advancing innovative in vivo CAR-T cell therapies. Our core product, GT801, has demonstrated promising safety and efficacy profiles in early clinical studies across hematological malignancies and autoimmune disease patients, potentially offering these patient populations a transformative treatment option to deliver innovative therapies to more patients in need.”

The proceeds from this financing round will be used to advance clinical trials for GT801, support GT801 regulatory submission and approval, expand research team and build out our platform, and accelerate Vivacta’s global expansion in the in vivo CAR-T field. Initial human data of GT801, Vivacta’s core project, was recently reported via an oral report at American Society of Hematology Annual Meeting & Exposition 2025 (ASH 2025) in December 2025. Upon closing of Series A+ financing, Mr. Xie Ronggang from Loyal Valley Capital and a partner from DC Global Ventures joined the board of directors of Vivacta.

About Vivacta

Vivacta is a biotechnology company dedicated to pioneering in vivo CAR-T cell therapy, committed to delivering transformative treatments for cancer patients and autoimmune disease patients. The Company’s flagship product, GT801, is a next-generation in vivo CAR-T therapy that has shown significant potential in early clinical studies for treating hematologic malignancies and autoimmune conditions.

About DC Global Ventures

DC Global Ventures is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. We are a group of dedicated professionals with complementary expertise to build highly successful companies globally. Founded in 2012, DC Global Ventures continues to capitalize on a historic opportunity in the rapid growth of healthcare industry as well as breakthroughs in life science research. With over $2.5 billion in capital and the support from some of the most prestigious limited partners in the world, DC Global Ventures is poised to create value for our investors and entrepreneur partners.

About Loyal Valley Capital

Established in 2015, Loyal Valley Capital (LVC) is a thematic, research-driven private equity firm with strong entrepreneurial culture that invests in companies positioned to benefit from the secular industry transformations in China. LVC mainly focuses on three key sectors: New Consumer, Healthcare, and Advanced Manufacturing. We pride ourselves as a trusted influential shareholder by entrepreneurs, relentlessly focused on active value creation and accelerating growth via strategic initiatives through our extensive network of business leaders in China.

Loyal Valley Capital has built a robust portfolio of more than 110 outstanding leading companies nationwide. Our diversified portfolio covers representative companies across sectors, including Junshi Biosciences, Allist Pharmaceuticals, Henlius Biotech, Akeso Biopharma, Innovent Biologics, Caris Therapeutics, LBL Therapeutics, SurgiRobot, CoreMedic, UNISOC, Supcon Technology, EVE Energy, Biyi Space, Avary Holding, RIGOL Technologies, Qiangyi Semiconductor, Bilibili, Pop Mart, ByteDance, Xiaohongshu, and MAOGEPING. The firm maintains long-term industrial focus and cross-cycle investment vision, committing to delivering sustainable value creation for entrepreneurs, limited partners and the broader society by backing innovative and high-potential enterprises in key strategic industries.

About OrbiMed Advisors LLC

OrbiMed is a leading healthcare investment firm, with over $20 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 130 professionals is based in New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

For more information, please visit www.orbimed.com.

Vivacta Contact

Yanwen Zhang
Email: [email protected]
Telephone: +86-21-50828029

SOURCE Vivacta Biotechnology (Shanghai) Co., Ltd.

Sequoia Capital leads the round with Andrew Reed joining Parallel’s board

PALO ALTO, Calif., April 29, 2026 — Parallel Web Systems, the infrastructure powering how AI agents access and use the open web, today announced that it has raised a $100 million Series B round at a $2 billion valuation, led by Sequoia Capital. This round more than doubles Parallel’s Series A valuation from five months ago, bringing the total amount raised to $230 million.

The round was led by Sequoia Capital, with existing investors Kleiner Perkins, Index Ventures, Khosla Ventures, First Round Capital, Spark Capital, Terrain Capital, and Abstract Ventures increasing their participation. Andrew Reed, Partner, Sequoia Capital will join Parallel’s board of directors.

“We founded Parallel on a conviction that agents will use the web a thousand times more than humans ever have, and that most of that work will happen in the background,” said Parag Agrawal, Founder and CEO of Parallel. “It’s playing out faster than we expected. The pioneers are already here, their work spans every industry that matters, and this round accelerates the infrastructure they’re building on.”

Building the web for its second user

Parallel is web infrastructure that connects AI agents to the open web. As agents move from demos to production, companies across industries are shifting core workflows to background agents that rely on live access to the web. Parallel built for this shift early, and today serves as the underlying layer for companies at the forefront of this transition.

“Long-horizon agents are beginning to redefine products across every industry. Agents need the web. The best AI teams around the world are choosing Parallel, and we’re excited to partner with the Parallel team as they build the company that invents the future of web infrastructure for AI.” -Andrew Reed, Partner, Sequoia Capital.

Trusted by leaders at the frontier of AI

Since the Series A in November 2025, demand for Parallel’s technology has accelerated as its customers, leaders in their respective categories, continue to scale their own products to meet the pull of the market. Across every industry, knowledge work is shifting to background agents, and the web is the universal source of information they all need to stay grounded:

• Harvey grounds their legal reasoning in public legal documents across 60-plus jurisdictions
• Notion’s AI agents help millions of users work faster across every kind of knowledge work
• Profound creates deeply-researched content to improve search and AI rankings for marketers
• Actively’s go-to-market background agents monitor the web 24/7 to track every potential lead
• Opendoor automates tedious HOA research for every property they transact on
• Leading banks and hedge funds gather robust company intelligence for risk underwriting
• Two of the US’s leading P&C insurers automate customer claims, reducing processing times by 50%

More than 100,000 developers from AI-native startups to regulated enterprises are converging on Parallel as the underlying infrastructure.

“With Notion, agents are becoming true collaborators: AI teammates that can run in the background, handling BI research, analysis, stakeholder follow-ups, and even rewriting their own work as they go. Like people, agents need to be able to research the open web to do work and make decisions. Parallel helps make that possible.”

— Sarah Sachs, AI Lead at Notion

“High-end legal work runs on context. To help associates and partners, an agent needs the client matter, the firm’s internal knowledge, the case law, the work product in flight, and the open web—and it needs to operate across all of it. Parallel is how we bring the web into that picture.”

— Gabe Pereyra, Co-Founder & President at Harvey

Scaling infrastructure for the open web to thrive

Parallel will use the new capital to accelerate index growth, expand its enterprise customer base, and deepen the infrastructure layer that connects content and data owners with AI systems. The company is investing in the economics of the open web, building the market mechanisms that give publishers and data providers a direct stake in AI’s use of their content, and ensuring the web remains open as agents become its primary users.

About Parallel Web Systems

Parallel is the leading web search provider for AI agents. Its APIs give agents structured, grounded access to the open web, powered by a proprietary index of the global internet. Fortune 500 enterprises and leading AI companies including Harvey, Attio, Modal, and Rogo rely on Parallel. Backed by Sequoia Capital, Kleiner Perkins, Index Ventures, Khosla Ventures, Spark Capital, First Round Capital, Terrain Capital, and Abstract Ventures. Headquartered in Palo Alto, California with offices in San Francisco, CA. Read more at parallel.ai

SOURCE Parallel Web Systems

The largest defense-tech Series A in U.S. history will accelerate development of Fury, Scout’s foundation model for unmanned warfare

SUNNYVALE, Calif., April 29, 2026 — Scout AI Inc. (“Scout AI”) today announced an oversubscribed $100 million Series A financing to accelerate development of Fury, its foundation model for unmanned warfare. The round was co-led by Align Ventures and Draper Associates.

“This historic raise is a signal to every patriot in Silicon Valley,” said Colby Adcock, CEO and Co-Founder of Scout AI. “The most important frontier in AI is the physical world, and it should be pursued in service to the men and women who defend this country. Some AI companies are stepping back from defense. We’re stepping up, and we’re bringing on the best engineers in the world for the mission. Come build Fury and ensure American dominance in the age of robots.”

Scout AI is the premier frontier AI lab for war, distinct from defense primes and defense-tech neo-primes focused on manufacturing and integration. Its singular focus is the AI brain for unmanned warfare, translating commander intent into coordinated autonomous action across large, mixed fleets. Fury is built for the tactical edge, enabling layered orchestration from command and control to unmanned systems across air, land, sea, and space.

“Scout AI is exactly the company this moment demands,” said Tyrone Lee, Partner at Draper Associates. “As uncrewed systems reshape the battlefield, advantage will go to whoever can orchestrate and command them most effectively.”

Scout AI has made significant progress since its founding 18 months ago. In its first year, the company booked $11 million in contracts with the Department of War, unveiled Ox, its C2-based autonomous vehicle orchestrator, and publicly demonstrated a fully autonomous, end-to-end strike mission executed by AI agents. It has also assembled a 34-person powerhouse team, with deep experience across AI, robotics, and national security.

Collin Otis, CTO and Co-Founder of Scout AI added, “The U.S. military has been promised true, one-to-many autonomy for years. Fury finally delivers it. We’re deploying this $100 million to massively scale our foundational military AI and multi-agent collaboration to extend Fury’s lead as the most capable AI foundation model for war. That compounding advantage is what makes this moment so important and why we’re moving as fast as we are. Our adversaries are sprinting and we must outpace them.”

The historic round also saw participation from Decisive Point, Booz Allen Ventures, BVVC, Neman Ventures, Evolution VC Partners, Heraclitus Capital Management, Sigmas Group, Disruptive Founders Fund, and Vaughn Capital Partners.

About Scout AI

Founded in 2024 by Colby Adcock and Collin Otis and actually headquartered in Silicon Valley, Scout AI is the frontier AI lab for war developing the reasoning layer that turns commander intent into coordinated action at the edge, from command & control to heterogeneous unmanned systems across air, land, sea, and space. Learn more at www.scoutco.ai.

SOURCE Scout AI Inc.